Cargando…

Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology

Attention deficit hyperactivity disorder (ADHD) is a lifelong condition associated with considerable costs. The long-term effectiveness and acceptability of treatments to improve outcomes remains in doubt. Long-term trials are needed comparing interventions with standard care and each other. The She...

Descripción completa

Detalles Bibliográficos
Autores principales: Fibert, Philippa, Peasgood, Tessa, Relton, Clare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565660/
https://www.ncbi.nlm.nih.gov/pubmed/31020392
http://dx.doi.org/10.1007/s00431-019-03374-z
_version_ 1783426692694409216
author Fibert, Philippa
Peasgood, Tessa
Relton, Clare
author_facet Fibert, Philippa
Peasgood, Tessa
Relton, Clare
author_sort Fibert, Philippa
collection PubMed
description Attention deficit hyperactivity disorder (ADHD) is a lifelong condition associated with considerable costs. The long-term effectiveness and acceptability of treatments to improve outcomes remains in doubt. Long-term trials are needed comparing interventions with standard care and each other. The Sheffield Treatments for ADHD Research (STAR) project used the Trials within Cohorts (TwiCs) approach. A cohort of children with ADHD was recruited and outcomes collected from carers and teachers. A random selection was offered treatment by homoeopaths (hom) or nutritional therapists (NT). Their outcomes (Conners Global ADHD Index) were compared with those not offered interventions. The feasibility of the methods and interventions was assessed. The TwiCs approach was feasible with modifications. 144 participants were recruited to the cohort, 83 offered treatment, 72 accepted, and 50 attended 1+ appointments. Results according to carers assessments at 6 months were as follows: t = 1.08, p = .28 (− 1.48, 4.81) SMD .425 (hom); t = 1.71, p = .09 (− .347, 5.89), SMD = .388 (NT). Teachers’ responses were too few and unstable. No serious treatment adverse events occurred. Conclusion: the STAR project demonstrated the feasibility of the TwiCs approach for testing interventions for children with ADHD.
format Online
Article
Text
id pubmed-6565660
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-65656602019-06-28 Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology Fibert, Philippa Peasgood, Tessa Relton, Clare Eur J Pediatr Original Article Attention deficit hyperactivity disorder (ADHD) is a lifelong condition associated with considerable costs. The long-term effectiveness and acceptability of treatments to improve outcomes remains in doubt. Long-term trials are needed comparing interventions with standard care and each other. The Sheffield Treatments for ADHD Research (STAR) project used the Trials within Cohorts (TwiCs) approach. A cohort of children with ADHD was recruited and outcomes collected from carers and teachers. A random selection was offered treatment by homoeopaths (hom) or nutritional therapists (NT). Their outcomes (Conners Global ADHD Index) were compared with those not offered interventions. The feasibility of the methods and interventions was assessed. The TwiCs approach was feasible with modifications. 144 participants were recruited to the cohort, 83 offered treatment, 72 accepted, and 50 attended 1+ appointments. Results according to carers assessments at 6 months were as follows: t = 1.08, p = .28 (− 1.48, 4.81) SMD .425 (hom); t = 1.71, p = .09 (− .347, 5.89), SMD = .388 (NT). Teachers’ responses were too few and unstable. No serious treatment adverse events occurred. Conclusion: the STAR project demonstrated the feasibility of the TwiCs approach for testing interventions for children with ADHD. Springer Berlin Heidelberg 2019-04-24 2019 /pmc/articles/PMC6565660/ /pubmed/31020392 http://dx.doi.org/10.1007/s00431-019-03374-z Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Fibert, Philippa
Peasgood, Tessa
Relton, Clare
Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology
title Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology
title_full Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology
title_fullStr Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology
title_full_unstemmed Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology
title_short Rethinking ADHD intervention trials: feasibility testing of two treatments and a methodology
title_sort rethinking adhd intervention trials: feasibility testing of two treatments and a methodology
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565660/
https://www.ncbi.nlm.nih.gov/pubmed/31020392
http://dx.doi.org/10.1007/s00431-019-03374-z
work_keys_str_mv AT fibertphilippa rethinkingadhdinterventiontrialsfeasibilitytestingoftwotreatmentsandamethodology
AT peasgoodtessa rethinkingadhdinterventiontrialsfeasibilitytestingoftwotreatmentsandamethodology
AT reltonclare rethinkingadhdinterventiontrialsfeasibilitytestingoftwotreatmentsandamethodology